News about Global Pharma

Alembic Pharma Secures FDA Approval for Diltiazem Hydrochloride Capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Dilacor XR Extended-Release Capsules, 120 mg, 180 mg, and 240 mg, of Allergan Sales LLC (Allergan).

Global Pharma | 21/10/2024 | By Aishwarya |  1023

Akums Forges Licensing Deal with Triple Hair Group for Patented Topical Solution

This advanced formulation combines three unique medicaments to combat alopecia, a common condition affecting millions in India and worldwide.

Global Pharma | 21/10/2024 | By Aishwarya |  560

Informa Markets Announces 17th Edition of CPHI and PMEC India Expo in November

The CPHI & PMEC India Expo 2024 promises to be a transformative event for the pharmaceutical sector, bringing together over 50,000 industry professionals and 2,000 exhibitors, who will present more than 10,000 innovative products.

Global Pharma | 21/10/2024 | By Aishwarya |  733

Gland Pharma Welcomes Shyamakant Giri as New CEO

Giri is a business leader with over 25 years of strategic and operating experience in pharmaceuticals, devices, diagnostics and healthcare services in Indian and multinational organizations across Asia, Africa, MENA & LATAM markets.

Global Pharma | 21/10/2024 | By Aishwarya |  1198

BioLineRx Gets USPTO Allowance of New Composition of Matter Patent on Motixafortide

The patent strengthens BioLineRx's robust intellectual property (IP) estate and extends its patent protection on motixafortide in the US through December 2041.

Global Pharma | 18/10/2024 | By Aishwarya |  553

Factor Bioscience Signs Exclusive License Deal with Eterna Therapeutics

The agreement positions both companies with the potential to accelerate the development of advanced cell therapies in the oncology, rare disease, and autoimmune fields.

Global Pharma | 18/10/2024 | By Aishwarya |  694

Cellular Origins, Fresenius Kabi to Scale Up Automation of Cell and Gene Therapy Manufacturing

The agreement is designed with the goal of digitally and physically integrating Fresenius Kabi’s suite of cell therapy processing technologies within Cellular Origins’ CGT robotic manufacturing platform Constellation.

Global Pharma | 17/10/2024 | By Aishwarya |  671

VGXI Picks Cryoport to Support its Supply Chain Solutions to Boost Next-Gen Therapies

VGXI is a contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines and RNA medicines, and ADC applications.

Global Pharma | 16/10/2024 | By Aishwarya |  569

OneSource Secures Equity Commitments of USD 95 Million for Fundraising

The strong interest from leading investors reflects growing confidence in our capabilities and the immense potential of the CDMO sector emerging out of India.

Global Pharma | 16/10/2024 | By Aishwarya |  854

Lupin Introduces First Generic Version of Pred Forte in US

Being the first generic to be approved and launched, the company is entitled to 180-day competitive generic therapy (CGT) exclusivity.

Global Pharma | 16/10/2024 | By Aishwarya |  598